ArticleRSC advances2019
Functionalization of halloysite nanotubes by enlargement and layer-by-layer assembly for controlled release of the fungicide iodopropynyl butylcarbamate.
Article in RSC advances, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Iodopropynyl butylcarbamate (IPBC) is currently one of the most important fungicides widely used for industrial coatings and bamboo treatment. In this work, a controlled release composite with IPBC for inhibition of mold and stain fungi was prepared using enlarged halloysite nanotubes (HNTs) with layer-by-layer (LbL) assembly of polyelectrolyte multilayers. The acid-treated HNTs retained their tubular structure with increased internal diameter, and IPBC loading efficiency was therefore increased to 24.4%, approximately three times the amount of raw HNTs (8.4%).
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.